Cargando…

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients

BACKGROUND: Sputum induction is a non-invasive method for obtaining measurements of inflammation in the airways. Whether spontaneously sampled sputum can be a valid surrogate is unknown. The aim of this study was to compare levels of six inflammatory markers in sputum pairs consisting of induced and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tangedal, Solveig, Aanerud, Marianne, Persson, Louise JP, Brokstad, Karl A, Bakke, Per S, Eagan, Tomas M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237726/ https://www.ncbi.nlm.nih.gov/pubmed/25398249 http://dx.doi.org/10.1186/s12931-014-0138-6

Ejemplares similares

Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients
por: Tangedal, Solveig, et al.
Publicado: (2017)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
por: Persson, Louise J. P., et al.
Publicado: (2015)

Predictors of Exacerbations in Chronic Obstructive Pulmonary Disease - Results from the Bergen COPD Cohort Study
por: Husebø, Gunnar R., et al.
Publicado: (2014)

The airway microbiota and exacerbations of COPD
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D
por: Persson, Louise Jeanette Pauline, et al.
Publicado: (2012)

Respiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health survey
por: Voll-Aanerud, Marianne, et al.
Publicado: (2010)

Diffusion capacity and CT measures of emphysema and airway wall thickness – relation to arterial oxygen tension in COPD patients
por: Saure, Eirunn Waatevik, et al.
Publicado: (2016)

Protected sampling is preferable in bronchoscopic studies of the airway microbiome
por: Grønseth, Rune, et al.
Publicado: (2017)

Guideline adherence in hospital recruited and population based COPD patients
por: Jouleh, Bahareh, et al.
Publicado: (2018)

Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients
por: Erdal, Marta, et al.
Publicado: (2016)

The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease
por: Knudsen, Kristel S., et al.
Publicado: (2022)

The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiences
por: Grønseth, Rune, et al.
Publicado: (2014)

The association of tidal EFL with exercise performance, exacerbations, and death in COPD
por: Aarli, Bernt Boegvald, et al.
Publicado: (2017)

Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD
por: Aaron, Shawn D, et al.
Publicado: (2010)

Lung hyperinflation and functional exercise capacity in patients with COPD – a three-year longitudinal study
por: Aalstad, Linn T., et al.
Publicado: (2018)

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
por: Pedersen, Frauke, et al.
Publicado: (2021)

Correlation of Clinical Symptoms and Sputum Inflammatory Markers with Air Pollutants in Stable COPD Patients in Beijing Area
por: Guo, Chenxia, et al.
Publicado: (2020)

Factors associated with coronary heart disease in COPD patients and controls
por: Svendsen, Christina D., et al.
Publicado: (2022)

Airway obstruction, dynamic hyperinflation, and breathing pattern during incremental exercise in COPD patients
por: Frisk, Bente, et al.
Publicado: (2014)

Median regression spline modeling of longitudinal FEV(1) measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients
por: Conrad, Douglas J., et al.
Publicado: (2017)

The effect of azithromycin on sputum inflammatory markers in bronchiectasis
por: Terpstra, L. C., et al.
Publicado: (2023)

Bacteria and sputum inflammatory cell counts; a COPD cohort analysis
por: Beech, Augusta S., et al.
Publicado: (2020)

Identification of COPD Inflammatory Endotypes Using Repeated Sputum Eosinophil Counts
por: Beech, Augusta, et al.
Publicado: (2022)

Peak oxygen uptake and breathing pattern in COPD patients – a four-year longitudinal study
por: Frisk, Bente, et al.
Publicado: (2015)

Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation
por: Barta, Imre, et al.
Publicado: (2022)

TNF-α is associated with loss of lean body mass only in already cachectic COPD patients
por: Eagan, Tomas ML, et al.
Publicado: (2012)

Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD
por: Kunz, Lisette IZ, et al.
Publicado: (2011)

The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis
por: Knudsen, Kristel S., et al.
Publicado: (2022)

Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls
por: Kawayama, Tomotaka, et al.
Publicado: (2016)

Complications and discomfort after research bronchoscopy in the MicroCOPD study
por: Leiten, Elise Orvedal, et al.
Publicado: (2020)

Relationship between sputum inflammatory markers and osmotic airway hyperresponsiveness during induction of sputum in asthmatic patients.
por: Jang, A. S., et al.
Publicado: (2001)

Sputum microbiology predicts health status in COPD
por: Braeken, Dionne CW, et al.
Publicado: (2016)

Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD
por: Balbi, Bruno, et al.
Publicado: (2019)

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients
por: Paone, Gregorino, et al.
Publicado: (2011)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation
por: Mercer, PF, et al.
Publicado: (2005)

A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD
por: Baines, Katherine J, et al.
Publicado: (2020)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ovnblqfakcvathf0iq6aprr01c